Seeing Is Believing
Currently out of the existing stock ratings of Ann Hynes, 141 are a HOLD (36.62%), 244 are a BUY (63.38%).
Analyst Ann Hynes, currently employed at MIZUHO, carries an average stock price target met ratio of 76.37% that have a potential upside of 12.35% achieved within 194 days.
Ann Hynes’s has documented 777 price targets and ratings displayed on 30 stocks. The coverage is on Healthcare, Communication Services sectors.
Most recent stock forecast was given on ELV, Elevance Health at 05-Nov-2024.
Analyst best performing recommendations are on PPD (PPD).
The best stock recommendation documented was for DPLO (DIPLOMAT PHARMACY) at 11/7/2017. The price target of $20 was fulfilled within 1 day with a profit of $1.25 (6.67%) receiving and performance score of 66.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$90
$52.18 (137.97%)
$90
1 months 17 days ago
(04-Oct-2024)
2/11 (18.18%)
$34.2 (61.29%)
133
Buy
$76
$38.18 (100.95%)
$83
1 months 22 days ago
(30-Sep-2024)
2/10 (20%)
$12.59 (19.85%)
304
Buy
$94
$56.18 (148.55%)
$94
2 months 1 days ago
(20-Sep-2024)
0/6 (0%)
$17.6 (23.04%)
Hold
$75
$37.18 (98.31%)
$68
3 months 19 days ago
(02-Aug-2024)
9/9 (100%)
$2.63 (3.63%)
95
Buy
$91
$53.18 (140.61%)
$101
6 months 4 days ago
(17-May-2024)
1/4 (25%)
$24.65 (37.15%)
70
Which stock is Ann Hynes is most bullish on?
Which stock is Ann Hynes is most reserved on?
What Year was the first public recommendation made by Ann Hynes?